KAI1 is a potential target for anti-metastasis in pancreatic cancer cells

Table 3 Analyses of liver and lung metastases with and without KAI1 transfection in mice in vivo (mean ± SD)

	Group	n	Liver weight (g)	t	P	Lung weight (g)	t	P
	Control	6	1.62 ± 0.39			0.45 ± 0.09
A	KAI1-LipofectAMINE	6	0.99 ± 0.21	2.661	< 0.05	0.30 ± 0.09	3.181	< 0.05
	pCMV-KAI1	6	1.01 ± 0.27	2.295	< 0.05	0.33 ± 0.09	2.291	< 0.05
	Control	6	1.62 ± 0.39			0.45 ± 0.09
B	KAI1-LipofectAMINE	6	1.69 ± 0.17	0.312	> 0.05	0.38 ± 0.03	1.348	> 0.05
	pCMV-KAI1	6	1.46 ± 0.28	1.286	> 0.05	0.36 ± 0.04	1.956	> 0.05

P < 0.05 between KAI1 transfection and controls.